News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Women news

Show

From To
Activism
‘TAC protected the man who sexually harassed me’

One of South Africa's most influential civil society organisations and its leaders may have flouted justice to protect a close ally, according to the woman who dared to speak up about her sexual harassment.

Published
21 July 2019
From
Health-e
Women
The New Face of HIV and Treating the 'Hardly Reached'

Physicians, scientists, government agencies, and companies are questioning whether the way they've always recruited for clinical trials still serves patients.

Published
20 July 2019
From
Medscape (requires free registration)
Microbicides
The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa. But, as the Bhekisisa Centre for Health Journalism reports, popping a pill every day to stay HIV-negative may not be for everyone. For young women, hassle-free alternatives are on the horizon.

Published
20 July 2019
From
Mail & Guardian
Structural factors
Can free schools in South Africa reduce HIV risk?

In our study, we wanted to examine why adolescent girls are engaging in risky sexual behaviour. Is this behaviour driven by childhood adversity, such as poverty, coming from a family where someone is ill with HIV/AIDS, or exposure to violence and experiencing psychological distress? We also wanted to find out if a government policy such as free schooling has the potential to mitigate some, or all, of these drivers.

Published
17 July 2019
From
The Conversation
History of HIV and AIDS
These Women Are Forgotten HIV Warriors

The legacy of straight women in the early fight against the AIDS epidemic should not be underrated.

Published
15 July 2019
From
HIV Plus
PrEP programmes and uptake
PrEP Trials Offer Insight for Reaching at-Risk Women in Sub-Saharan Africa

Reaching individuals at high risk of acquiring HIV infection continues to pose a challenge to uptake of HIV pre-exposure prophylaxis (PrEP). A new study looked at PrEP clinical trials in sub-Saharan Africa, examining recruitment strategies to reach women at high risk of contracting HIV.

Published
10 July 2019
From
Contagion Live
Heterosexual men
Older, out-of-school and anonymous partners pose more HIV infection risk for adolescent girls in South Africa

South African research has found that adolescent girls and young women (aged 13-23) were more than twice as likely to be infected with HIV by older men

Published
28 June 2019
By
Krishen Samuel
Side-effects
Cases of hair loss among African-American women reported after switch to new tenofovir formula

Hair loss (alopecia) occurred in six African-American women living with HIV after switching to the new formula of tenofovir, clinicians report in Open Forum Infectious Diseases. The

Published
26 June 2019
By
Michael Carter
PrEP policies and guidelines
US: Federal Guidelines May Inadvertently Restrict Women’s Access to Effective HIV Protection

Restrictive recommendations for pre-exposure prophylaxis (or PrEP) issued by the Centers for Disease Control and Prevention (CDC) systematically disqualified nearly all women at risk for HIV and/or motivated to use the medication, researchers at the Yale School of Public Health and George Washington University have found.

Published
25 June 2019
From
Yale School of Public Health
PrEP programmes and uptake
Study illuminates PrEP treatment pathway and its facilitators and barriers for women in the Bronx

Self-perceived HIV risk, learning about pre-exposure prophylaxis (PrEP) via trusted sources, positive healthcare experiences and health insurance coverage are facilitators of PrEP initiation and continuation for at-risk minority

Published
17 June 2019
By
Michael Carter
← First12345...70Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.